Cholestenoic acid is a prognostic biomarker in acute respiratory distress syndrome
JH Madenspacher, RD Stapleton, BT Suratt… - Journal of Allergy and …, 2019 - jacionline.org
This study was supported by the Austrian Science Fund (Fonds zur Förderung der
wissenschaftlichen Forschung [FWF]) via grant number F4605 and the FWF-funded PhD
programs Inflammation and Immunity (IAI) and Molecular, Cellular and Clinical Allergology
(MCCA). RV is recipient of a megagrant of the Government of the Russian Federation (grant
no. 14. W03. 31.0024). Disclosure of potential conflict of interest: R. Valenta has received
research grants from Biomay AG, Vienna, Austria, and Viravaxx, Vienna, Austria, and serves …
wissenschaftlichen Forschung [FWF]) via grant number F4605 and the FWF-funded PhD
programs Inflammation and Immunity (IAI) and Molecular, Cellular and Clinical Allergology
(MCCA). RV is recipient of a megagrant of the Government of the Russian Federation (grant
no. 14. W03. 31.0024). Disclosure of potential conflict of interest: R. Valenta has received
research grants from Biomay AG, Vienna, Austria, and Viravaxx, Vienna, Austria, and serves …